Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America
Voyageur Pharmaceuticals CEO Brent Willis signs a significant sales contract for the Latin American market, marking a milestone for the company and positioning it for growth and expansion.
The signing of the sales contract by Voyageur Pharmaceuticals marks a significant step forward for the company, positioning it for growth and expansion in the Latin American market. This news signifies potential market success for the company's flagship product, SmoothX®2% w/v, and reflects its commitment to driving sales growth through strategic distribution partnerships.